ArticleHepatology international2015
Twenty-year survival post-liver transplant: challenges and lessons.
Article in Hepatology international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Twenty-year longitudinal follow-up after liver transplantation: a single-center experience with 251 consecutive patients.Korean journal of transplantation · 2022Article
- The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.Hepatology (Baltimore, Md.) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There have been numerous reports on survival outcomes after liver transplantation with short-term and mid-term follow-up. However, only a few reports are available for 20-year long-term survivors after liver transplantation. In Korea, the first successful deceased donor liver transplantation (DDLT) in a 13-year-old Wilson's disease patient was performed in 1988, and the first successful living donor liver transplantation (LDLT) in 9-month biliary atresia patient was performed in 1994. Because of the severe shortage of deceased donors and delayed launching of LDLT from December 1994, only 38 cases of liver transplantation (two pediatric LDLTs and 36 DDLTs) from 1988 to 1994 were included in this study (Strong and Fawcett, Hepatol Int 2015 [1]. doi: 10.1007/s12072-015-9617-1) to investigate more than 20-year survivors. Six adult recipients after DDLT and three pediatric recipients (one DDLT, two LDLTs) are alive now with normal liver function in Korea. Twenty-year survivors after DDLT and LDLT do not show that significant co-morbidities related to long-term immunosuppression and high-dose indefinite HBIG monotherapy has shown the reliable modality to prevent HBV-reinfection for HBV-related liver transplant candidates.
Indexed as
Identifiers
25820798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.